Home » Topics » BioWorld Science

BioWorld Science
RSS

Vipergen and PhoreMost enter into multitarget drug discovery agreement

Sep. 15, 2021

Theseus Pharmaceuticals divulges EGFR mutant inhibitors

Sep. 15, 2021

U.S. researchers patent new compounds for malaria

Sep. 15, 2021

eIF4A3 identified as possible therapeutic target for cancer

Sep. 15, 2021

Mindset Pharma shows MSP-1014 is comparable to psilocybin in drug discrimination assay

Sep. 15, 2021

Targeting late inflammation via complement system ameliorates TBI-induced epilepsy

Sep. 15, 2021

Latrophilin-3 induces urothelial tumorigenesis and is a therapeutic target

Sep. 15, 2021

AZD-0095, selective MCT4 inhibitor with excellent potency in cancer models

Sep. 15, 2021

A subset of EGFR-mutant, MET-amplified lung cancers relies only on MET activation for survival

Sep. 15, 2021

ZDWX-25, GSK-3beta/DYRK1A dual inhibitor with promising activity in models of AD

Sep. 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026